Immunic's Series A - II Round

Immunic raised a round of funding on September 05, 2017.

Immunic is a start-up biotech company founded in April 2016 and focused on the development of orally available, small molecule immune modulators to block immune and autoimmune responses. Immunic devel…

Articles about Immunic's Series A - II Round: